Skip to site menu Skip to page content

Thank you.

Please check your email to download the Product.

Flexible Manufacturing

Flexible Manufacturing-prodcut-feature-image

Catalent's launch of Safinamide

Safinamide is the first new molecule in 20 years to be used in the treatment of Parkinson’s.

Zambon s.p.A. entrusted Catalent as its partner for timely development and launch of Safinamide under the brand name Xadago® to a worldwide target market.

Related Content